Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Windia Chemicals is an Indian pharmaceutical company that specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced chemical intermediates. Founded in 1994 and based in Hyderabad, the company operates manufacturing facilities focused on the production of bulk drugs for the global market, with a particular emphasis on quinolone-based antibiotics. Their product portfolio includes key intermediates for widely used anti-infective agents such as Norfloxacin and Ciprofloxacin. Windia Chemicals serves as a contract manufacturing partner for various pharmaceutical firms, providing cost-efficient chemical synthesis and scale-up services under regulatory standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Windia Chemicals.